Transsphenoidal hypophysectomy in the clinically normal dog.
Pituitary function and short-term clinical effects after transsphenoidal hypophysectomy were investigated in clinically normal dogs. In study I, 8 dogs were given polyionic fluids IV during the first 12 hours after surgery. In study II, 4 dogs were given polyionic fluids IV and glucocorticoid supplementation for 7 days. Pituitary function was assessed by evaluating basal ACTH concentrations and results of a growth hormone stimulation test before and 1 and 12 weeks after hypophysectomy, an ACTH stimulation test, a thyrotropin-releasing hormone-stimulation test, and a modified water deprivation/vasopressin response test before and 1, 4, 8, and 12 weeks after hypophysectomy. Gross and histologic evaluations of the surgery site, thyroid and adrenal glands, and skin were done at 12 weeks after surgery. Four dogs from study I died within 27 hours after hypophysectomy. Postmortem examinations of these dogs revealed liver and lung congestion compatible with circulatory collapse. None of the dogs in study II died. For the surviving dogs in both studies, diabetes insipidus developed immediately after hypophysectomy and resolved within 2 weeks. Hypernatremia also developed immediately after hypophysectomy and resolved by 1 week. Production of ACTH was evident at 1 and 12 weeks after hypophysectomy in all dogs, and results of ACTH stimulation tests after surgery were not notably different from results obtained before surgery. Results of thyrotropin-releasing hormone stimulation and growth hormone-stimulation tests supported the diagnosis of hypothyroidism and hyposomatotropism attributable to hypophysectomy. Histologic examination revealed thyroid atrophy, epidermal and dermal atrophy, and normal adrenal glands in all dogs and remnants of the hypophysis in 2 dogs from study I.(ABSTRACT TRUNCATED AT 250 WORDS)
Lantz
G C
GC
Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Purdue University, West Lafayette, IN 47907.
Ihle
S L
SL
Nelson
R W
RW
Carlton
W W
WW
Feldman
E C
EC
Lothrop
C D
CD
Bottoms
G D
GD
D000324:Adrenocorticotropic Hormone / Q000097:blood; D000818:Animals; D003919:Diabetes Insipidus / Q000209:etiology / Q000662:veterinary; D004283:Dog Diseases / Q000209:etiology; D004285:Dogs / Q000502:physiology / Q000601:surgery*; D005260:Female; D013006:Growth Hormone / Q000097:blood; D007016:Hypophysectomy / Q000662:veterinary*; D007671:Kidney Concentrating Ability; D011183:Postoperative Complications / Q000662:veterinary; D013100:Sphenoid Bone; D013973:Thyrotropin-Releasing Hormone; D013974:Thyroxine / Q000097:blood; D013997:Time Factors; D014284:Triiodothyronine / Q000097:blood
D014284:Triiodothyronine; D013973:Thyrotropin-Releasing Hormone; D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone; D013974:Thyroxine